TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3027% below fair value
$96.43+2.52 (+2.68%)
Close on Nov 18, 2026Market cap $3.34BP/E 25.0Yield 0.00%
TransMedics total assets
Total assets on the balance sheet at the end of each period.
TransMedics's total assets was $1.46B at Jun 30, 2026. For fiscal 2025 it was $1.07B, up 32.9% from the year before. The highest annual figure on record is $1.07B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.07B | +32.9% |
| FY2024 | Dec 31, 2024 | $804.08M | +13.9% |
| FY2023 | Dec 31, 2023 | $706.05M | +154.8% |
| FY2022 | Dec 31, 2022 | $277.15M | +105.5% |
| FY2021 | Dec 31, 2021 | $134.89M | -11.3% |
| FY2020 | Dec 31, 2020 | $152.03M | +44.4% |
| FY2019 | Dec 28, 2019 | $105.30M | +149.8% |
| FY2018 | Dec 29, 2018 | $42.16M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.46B | +64.4% |
| Q1 FY2026 | Mar 31, 2026 | $1.43B | +71.3% |
| Q4 FY2025 | Dec 31, 2025 | $1.07B | +32.9% |
| Q3 FY2025 | Sep 30, 2025 | $946.03M | +20.4% |
| Q2 FY2025 | Jun 30, 2025 | $890.52M | +17.4% |
| Q1 FY2025 | Mar 31, 2025 | $837.53M | +15.7% |
| Q4 FY2024 | Dec 31, 2024 | $804.08M | +13.9% |
| Q3 FY2024 | Sep 30, 2024 | $785.57M | +14.0% |
| Q2 FY2024 | Jun 30, 2024 | $758.58M | +9.9% |
| Q1 FY2024 | Mar 31, 2024 | $723.83M | +152.1% |
| Q4 FY2023 | Dec 31, 2023 | $706.05M | +154.8% |
| Q3 FY2023 | Sep 30, 2023 | $689.23M | +150.7% |
| Q2 FY2023 | Jun 30, 2023 | $690.36M | +488.6% |
| Q1 FY2023 | Mar 31, 2023 | $287.09M | +131.5% |
| Q4 FY2022 | Dec 31, 2022 | $277.15M | +105.5% |
| Q3 FY2022 | Sep 30, 2022 | $274.87M | +109.6% |
| Q2 FY2022 | Jun 30, 2022 | $117.29M | -16.5% |
| Q1 FY2022 | Mar 31, 2022 | $124.01M | -14.9% |
| Q4 FY2021 | Dec 31, 2021 | $134.89M | -11.3% |
| Q3 FY2021 | Sep 30, 2021 | $131.15M | -17.7% |
| Q2 FY2021 | Jun 30, 2021 | $140.51M | -13.9% |
| Q1 FY2021 | Mar 31, 2021 | $145.78M | +50.4% |
| Q4 FY2020 | Dec 31, 2020 | $152.03M | +44.4% |
| Q3 FY2020 | Sep 30, 2020 | $159.32M | +41.5% |
| Q2 FY2020 | Jun 30, 2020 | $163.14M | +34.8% |
| Q1 FY2020 | Mar 31, 2020 | $96.92M | +150.1% |
| Q4 FY2019 | Dec 28, 2019 | $105.30M | +149.8% |
| Q3 FY2019 | Sep 28, 2019 | $112.62M | – |
| Q2 FY2019 | Jun 29, 2019 | $121.01M | – |
| Q1 FY2019 | Mar 30, 2019 | $38.76M | – |
| Q4 FY2018 | Dec 29, 2018 | $42.16M | – |
See a number that looks wrong?